We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byMelanie Grooms
Modified about 1 year ago
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma by Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Daniela Donnarumma, Claudia Crippa, Mario Boccadoro, Giulia Perrone, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Luciano Masini, Anna Furlan, Annamaria Brioli, Daniele Derudas, Stelvio Ballanti, Maria Laura Dessanti, Valerio De Stefano, Angelo Michele Carella, Magda Marcatti, Andrea Nozza, Felicetto Ferrara, Vincenzo Callea, Catello Califano, Annalisa Pezzi, Anna Baraldi, Mariella Grasso, Pellegrino Musto, and Antonio Palumbo Blood Volume 120(1):9-19 July 5, 2012 ©2012 by American Society of Hematology
CONSORT diagram of patient flow through the study. Michele Cavo et al. Blood 2012;120:9-19 ©2012 by American Society of Hematology
Analysis of outcomes from the start of consolidation therapy with VTD or TD. Kaplan-Meier curves for TTP (A), PFS (B), and OS (C) from the landmark of starting consolidation therapy. *P value according to log-rank test. Michele Cavo et al. Blood 2012;120:9-19 ©2012 by American Society of Hematology
Kaplan-Meier curves for PFS from the landmark of starting consolidation therapy. Michele Cavo et al. Blood 2012;120:9-19 ©2012 by American Society of Hematology
Kaplan-Meier curves for PFS from the landmark of starting consolidation therapy according to the presence or absence of cytogenetic abnormalities. Michele Cavo et al. Blood 2012;120:9-19 ©2012 by American Society of Hematology
Kaplan-Meier curves for PFS from the landmark of starting consolidation therapy according to t(4;14) positivity or negativity. Michele Cavo et al. Blood 2012;120:9-19 ©2012 by American Society of Hematology
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Pertuzumab in Combination with Trastuzumab and Docetaxel in Elderly Patients with HER2-Positive Metastatic Breast Cancer in the CLEOPATRA Study Miles D.
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL by Arian.
Imedex Frontline Therapy and Maintenance for Newly Diagnosed Multiple Myeloma –Transplant eligible vs transplant ineligible –Doublets vs triplets.
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Apparent Diffusion Coefficient in recurrent Glioblastoma treated with Bevacizumab Oscar S. Chirife, Teresa Pujol, Joan Berenguer, Javier Moreno, Izaskun.
By Dr. Olga Korosteleva Todays Talk: Surviving Survival Analysis By Kelley Mizukami.
Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Barts Cancer Institute Rebecca Auer Waldenstrom’s: The Future.
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men by Bas de Laat, Philip G. de Groot, Ronald H.
Allogeneic Transplant Following Brentuximab Vedotin Treatment in Patients with Relapsed or Refractory CD30+ Lymphomas Illidge T et al. Proc ASH 2011;Abstract.
Dr A. ASSAL French Blood Services (EFS) PARIS. FRANCE Second WHO consultation January 27 & 28 January, 2009 Standardization of PCR for Trypanosoma cruzi.
The Reliable Life Defense. Each vial contains: Each vial contains: Recombinant human granulocyte colony-stimulating factor (G-CSF) 300 µg in a volume.
Effect of Thalidomide on clinical remission in children and adolescents with refractory Crohn’s disease P. S. KUNDHAL ET AL. JAMA November, 2013 Moderator.
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
Management of Multiple Myeloma Irza Wahid Subdivision of Hematology – Medical Oncology Departement of Internal Medicine Medical Faculty, Andalas University.
Chapter Six Demand. Properties of Demand Functions u Comparative statics analysis of ordinary demand functions -- the study of how ordinary demands x.
STEM CELL BIOENGINEERING Cláudia Lobato da Silva Research activities at Centro de Engenharia Biológica e Química.
©2011 Elsevier, Inc. Molecular Tools and Infectious Disease Epidemiology Betsy Foxman Chapter 8 Determining the Reliability and Validity and Interpretation.
New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong.
By Gavin McGerald ProductsProducts Objective: to review rules for multiplying real numbers.
Management of Hyperglycemia in the Noncritical Care Setting 1.
4.4 Rational Root Theorem. Rational Root Theorem give direction in testing possible zeros. Let a 0 x n + a 1 x n-1 + …a n-1 x + a n = 0 represent a polynomial.
WHEN TO CONSIDER RRT Timothy E Bunchman Founder PCRRT
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
MGUS (interpreting the test you didnt order) Family Medicine Review Course 2011 Christian Cable, MD, FACP.
Optimal Antifungal Prophylaxis The Case for Posaconazole Oliver A. Cornely, MD, FIDSA Dep. I for Internal Medicine Hematology - Oncology Infectious Diseases.
2-3 Direct Variations. Direct Variation: y = kx y varies directly with x y varies directly as x k = constant of variation = slope The graph of a direct.
Integers Free powerpoints at
Inflammation and Neurodegeneration in Multiple Sclerosis John DeLuca, PhD Vice President for Research Kessler Foundation West Orange, New Jersey Claudia.
© 2016 SlidePlayer.com Inc. All rights reserved.